NetScientific PLC (GB:EMVC)

LSE:EMVC

EMVC

NetScientific

RESEARCH TOOLSreports

NetScientific (EMVC) Price & Analysis

6 Followers

EMVC Stock Chart & Stats

60.50 p

1.90 p(3.52%)

At close: Jan 09 4:00 PM EST

60.50 p

1.90 p(3.52%)

Day’s Range― - ―

52-Week Range34.00 p - 62.00 p

Previous CloseN/A

Volume700.00

Average Volume (3M)31.99K

Market Cap

£14.40M

Enterprise Value15.34M

Total Cash (Recent Filing)£548.00K

Total Debt (Recent Filing)£1.49M

Price to Earnings (P/E)―

Beta0.65

Next Earnings

May 20, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding27,967,531

10 Day Avg. Volume35,929

30 Day Avg. Volume31,987

Financial Highlights & Ratios

PEG Ratio-0.21

Price to Book (P/B)0.78

Price to Sales (P/S)4.82

P/FCF Ratio-5.99

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-0.04

Revenue Forecast (FY)£3.42M

Bulls Say, Bears Say

Bulls Say

Revenue GrowthStrong revenue growth indicates potential for market expansion and increased demand for NetScientific's portfolio companies' innovations.

Low LeverageLow leverage enhances financial stability, providing flexibility to invest in growth opportunities without excessive debt burden.

Equity BaseA strong equity base supports long-term growth and stability, enabling the company to withstand financial challenges and invest in its portfolio.

Bears Say

Profitability ChallengesOngoing profitability challenges can hinder sustainable growth and shareholder value, requiring strategic improvements in cost management.

Negative Cash FlowNegative cash flow from operations limits the company's ability to self-fund growth and increases reliance on external financing.

Negative ReturnsNegative returns on equity indicate challenges in generating shareholder value, impacting investor confidence and long-term investment appeal.

NetScientific News

EMV Capital to Spotlight Vortex and DName-iT in Investor Portfolio Event

The latest announcement is out from NetScientific ( ($GB:EMVC) ). EMV Capital plc will host a virtual “Meet...

2M ago

EMV Capital Lifts AUM Past £100m as Venture Platform and Portfolio Deliver in 2025

NetScientific ( ($GB:EMVC) ) has provided an update. EMV Capital reported strong operational momentum in 2025, with assets...

2M ago

EMV Capital Discloses PDMR Share Transfer with No Change in Beneficial Holding

The latest update is out from NetScientific ( ($GB:EMVC) ). EMV Capital plc has disclosed a transaction by...

3M ago

EMV Capital-backed Sofant Secures £6.25m to Pivot from R&D to Commercial Rollout

NetScientific ( ($GB:EMVC) ) has shared an update. EMV Capital’s portfolio company Sofant Technologies has raised around £6.25m...

4M ago

EMV Capital Discloses Director’s Internal Share Transfer With Holding Unchanged

NetScientific ( ($GB:EMVC) ) has provided an update. EMV Capital plc reported an internal share transfer by Senior...

4M ago

Wanda Health Secures £0.86 Million to Boost US Expansion

An announcement from NetScientific ( ($GB:EMVC) ) is now available. Wanda Health, a portfolio company of EMV Capital,...

4M ago

EMV Capital Issues New Shares to Directors, Boosting Market Confidence

NetScientific ( ($GB:EMVC) ) has provided an update. EMV Capital plc has announced the issuance of 200,141 new...

4M ago

EMV Capital Expands Finance Leadership to Support Growth

NetScientific ( ($GB:EMVC) ) has issued an update. EMV Capital plc has announced a significant expansion of its...

4M ago

EMV Capital to Host Virtual Portfolio Showcase

NetScientific ( ($GB:EMVC) ) just unveiled an announcement. EMV Capital plc announced a virtual ‘Meet the Portfolio’ event...

5M ago

EMV Capital Reports Resilient Interim Results Amid Market Challenges

The latest update is out from NetScientific ( ($GB:EMVC) ). EMV Capital plc reported its interim results for...

6M ago

EMVC FAQ

What was NetScientific PLC’s price range in the past 12 months?

NetScientific PLC lowest share price was 34.00 p and its highest was 62.00 p in the past 12 months.

What is NetScientific PLC’s market cap?

NetScientific PLC’s market cap is £14.40M.

When is NetScientific PLC’s upcoming earnings report date?

NetScientific PLC’s upcoming earnings report date is May 20, 2026 which is in 42 days.

How were NetScientific PLC’s earnings last quarter?

Currently, no data Available

Is NetScientific PLC overvalued?

According to Wall Street analysts NetScientific PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does NetScientific PLC pay dividends?

NetScientific PLC does not currently pay dividends.

What is NetScientific PLC’s EPS estimate?

NetScientific PLC’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does NetScientific PLC have?

NetScientific PLC has 27,967,531 shares outstanding.

What happened to NetScientific PLC’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of NetScientific PLC?

Currently, no hedge funds are holding shares in GB:EMVC

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

NetScientific PLC

EMV Capital plc is a venture capital firm specializing in seed, growth capital, early and mid stage investments. The firm focuses to invest in sustainability, life science, technology, transformative biomedical, deep tech, semiconductors, industrials, robotics, AI and healthcare technologies focusing on digital health, diagnostics, and therapeutics sectors. It also prefers to invest in companies that significantly improve the health and well-being of people with chronic diseases. Within digital health it focuses on data analytics, wearable technologies, and devices. The firm seeks to invest in companies based in European developed markets, United Kingdom and in the United States. It typically invests up to £15 million ($20.32 million), but may consider larger amounts. It prefers to hold a controlling interest in all principal subsidiaries. The firm prefers to invest through its balance sheet investments. EMV Capital plc was founded in 2008 and is based in London, United Kingdom with additional office in Beaconsfield, United Kingdom.